Efficacy of amlodipine in the treatment of stable effort angina. An echocardiographic stress study

Clinical Drug Investigation

Volumn 13, Issue SUPPL. 1, 1997, Pages 108-112

  Vizza, Carmine Dario ^a,b   Sciomer, Susanna ^a   Giustini, Anna ^a   Dagianti, Alessandra ^a   Fedele, Francesco ^a   Dagianti, Armando ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b POLICLINICO UMBERTO I   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; CORONARY VASODILATING AGENT;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EXERCISE TEST; FEMALE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE OXYGEN CONSUMPTION; HEART RATE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 0030757983     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-199700131-00019     Document Type: Article

References (14)

1. Faulkner JK, McGibney D, Chausseaud LF, et al. The pharmacokinetics of amlodipine in healthy volunteers after single intravenous and oral doses and after 14 repeated doses given once daily. Br J Clin Pharmacol 1986; 22: 21-5
2. Williams DM, Cubeddu LX. Amlodipine pharmacokinetics in healthy volunteers. J Clin Pharmacol 1988; 28: 900-4
3. Heber ME, Brigden G, Al Khawaja I, et al. 24h blood pressure control with the once daily calcium antagonist, amlodipine. Br J Clin Pharmacol 1989; 27: 359-65
4. Webster J, Robb OJ, Jeffers TA, et al. Once-daily amlodipine in the treatment of mild to moderate hypertension. J Cardiovasc Pharmacol 1988; 12 Suppl. 7: 72-5
5. Frick MH, McGibney D, Tyler HM. A dose response study of amlodipine in mild to moderate hypertension. J Int Med 1989; 225: 101-5
6. Taylor SH, Lee P, Jackson N, et al. A double blind, placebo controlled, parallel dose-response study of amlodipine in stable exertional angina pectoris. J Cardiovasc Pharmacol 1991; 17 Suppl. 1: 46-9
7. Beckerman B. An open multicenter efficacy and safety evaluation of amlodipine in the treatment of symptomatic myocardial ischaemia. J Cardiovasc Pharmacol 1991; 17 Suppl. 1: 61-4
8. Chanine RA, Feldman RL, Giles TD, et al. Randomized placebo-controlled trial of amlodipine in vasospastic angina. J Am Coll Cardiol 1993; 21: 1365-70
9. Wann L, Faris J, Childress R, et al. Exercise cross-sectional echocardiography in ischaemic heart disease. Circulation 1979; 60: 1300-8
10. Robertson WS, Feigenbaum H, Armstrong WF, et al. Exercise echocardiography: a clinically practical addition in the evaluation of coronary artery disease. J Am Coll Cardiol 1983; 2: 1085-91
11. Glantz S. Primer of biostatistics. 3rd ed. New York: McGraw Hill, 1992
12. Lund-Johansen P, Omvick P, White W, et al. Long term haemodynamic effects of amlodipine at rest and during exercise in essential hypertension. J Hypertens 1990; 8: 1129-36
13. Mroczeck WJ, Burris JF, Allenby KS. A double blind evaluation of the effect of amlodipine on ambulatory blood pressure in hypertensive patients. J Cardiovasc Pharmacol 1988; 12 Suppl. 7: 579-84
14. Murdoch D, Heel RC. Amlodipine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular disease. Drugs 1991; 41: 478-505